Position in MYGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,169,670
-$2,562,120 QoQ
Shares Held
204,846
-0.3% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 196 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $180,210,639 across 15 Diagnostics & Research names. MYGN ranks #10 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
334,193 | $58,761,155 | |
| 2 | NTRA |
Natera, Inc.
|
143,275 | $38,891,998 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
160,130 | $30,940,318 | |
| 4 | A |
Agilent Technologies, Inc.
|
176,673 | $23,467,474 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
15,010 | $7,949,145 | |
| 6 | CSTL |
Castle Biosciences Inc
|
301,040 | $7,179,804 | |
| 7 | RVTY |
Revvity, Inc.
|
45,074 | $5,014,933 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
|
6,406 | $3,211,712 |
All Filings in MYGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,169,670 | 204,846 | Shares | Sole | 2026-08-06 | |
| 2022-06-30 | $3,731,790 | 205,382 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,930,822 | 155,985 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,317,578 | 156,434 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,733,649 | 146,598 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,473,211 | 146,279 | Shares | Sole | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||